Skip to the main content.

Sickle Cell Disease

PHASE 2

Case Studies

Here you can edit the background of the section

Key Takeaways

With the study underway, BBK Worldwide was hired to drive enrollment in an increasingly competitive marketplace — one in which it was important to move the target audience from a place of skepticism to a place of trust. 
 
BBK was asked to leverage the client’s original patient brochure as creative inspiration for the development of a dynamic recruitment campaign for the United States. With strong messages of empowerment for diverse audiences, BBK created materials that patients with sickle cell disease would personally identify with and that would generate interest.

I am Strong. Sickle Cell Disease

Increase-Referrals_ICONThe campaign exceeded client expectations with more than 1,000 referrals and 112 consented patients within 12 months.

Challenges and Insights


Time was of the essence due to the unmet need for innovative treatments as well as a competing study seeking a similar patient population.

Building trust with a patient population that has historically felt neglected or ignored was critical for success. The “patient voice” needed to be authentic to overcome skepticism about clinical trial participation.


The outreach needed to resonate with diverse audiences within the sickle cell disease community, including Hispanic, South Asian, Southern European Caucasian and Middle Eastern audiences.


With multiple social media platforms to consider, BBK’s media experts needed to develop a dynamic media plan that could deliver results in a timely, predictable manner.

 

Voices of SCD
sickle cell disease recruitment outreach

Solution

BBK worked with its DEI advisory board and patient focus groups to create messaging and visuals that would reach a diverse audience.

 

Tactics included:

  • Facebook

  • Instagram

  • Search Engine Marketing

  • Streaming Radio

  • Terrestrial Radio

  • Clinical Notifier Patient Database

  • College Outreach

 

strong-poster

Impact 

  • Participants_ICON 1,037 Number of highly qualified referrals generated in 12 months.

  • Increase-Referrals_ICON-1 9% Percentage of referrals that consented to participate (112) in the study (which had an enrollment goal of 88 patients).

  • Funnel-icon 662 Referrals generated by Instagram, which was the most successful tactic, resonating strongly with women ages 25-34.

Partnerships, including those with BlackDoctor.org and a smaller patient-facing advocacy group, raised awareness and built trust within the sickle cell disease community.
 
Leveraging BBK’s clinical trial platform, patients with SCD and SCD anemia within 10-20 miles of study sites were invited to consider study participation.
 
Sites were supported with on-site nurses to help facilitate the screening of referrals — ensuring patients were engaged while interest was at its peak. 

Download the PDF version of this case study today:

Subscribe to stay connected

Share this page:

Familial Amyloid Polyneuropathy — Neurology and Gene Therapy — Phase 3

case-studies-icon Case Studies

October 12, 2021

Pediatric Spinal Muscular Atrophy — Neurology and Rare Disease — Phase 2

case-studies-icon Case Studies

December 13, 2021

Major Depressive Disorder — Mental Health — Pivotal Phase 3 Study

case-studies-icon Case Studies

February 5, 2022

BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.

        Facebook LinkedIn YouTube
        Facebook LinkedIn YouTube

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.